WHO ICTRP trial
To Compare Longterm Single versus Dual Antiplatelet Therapy In Ischemic Stroke…
CTRI/2022/01/039445 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2022/01/039445 |
|---|---|
| Public title | To Compare Longterm Single versus Dual Antiplatelet Therapy In Ischemic Stroke due to atherosclerotic narrowing of blood vessel in the brain. |
| Scientific title | Longterm Single versus Dual Antiplatelet Therapy In Patients With Ischemic Stroke due to Intracranial Atherosclerotic Disease: A Randomized Trial. - STENOSIS |
| Primary sponsor | Dr Rohit Bhatia |
| Secondary sponsors | INSTRUCT Network |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: G811- Spastic hemiplegia |
| Interventions | Intervention1: Aspirin and Clopidogrel: Aspirin 75 mg and Clopidogrel 75 mg for a total of 12 months ( three months initially in both groups and then another 9 months in the intervention group) Control Intervention1: Aspirin and Placebo… |
| Registration date | Jan 14, 2022 |
| Target size | 2200 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: